SCHEMBL23181759

SCHEMBL23181759

CC1CCC2SCCNC2C1

nearest known ligand 0.52

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24098290 0.83 L3MBTL1 (0.40) L3MBTL1
SCHEMBL16877732 0.78
SCHEMBL15934226 0.75
SCHEMBL23181760 0.72 PNMT (0.35)
SCHEMBL13028620 0.70 MAPK1 (0.41)
SCHEMBL16877757 0.70
SCHEMBL21391150 0.69 L3MBTL1 (0.31) L3MBTL1
SCHEMBL3020679 0.69 L3MBTL1 (1.00) L3MBTL1
SCHEMBL16878156 0.67 PNMT (0.32)
SCHEMBL13722786 0.66 L3MBTL1 (0.60) L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021057970-A1 RET INHIBITOR, PHARMACEUTICAL COMPOSITION THEREOF AND USE THEREOF 广东东阳光药业有限公司 2021-04-01 WO disclosed